We are a specialized UK based consultancy firm with expert consultation services dedicated to the medical device healthcare industry organizations planning to expand their commercial footprint into the Middle East (Levant and Gulf regions). We understand the challenges faced by medical device companies in the initial phase of growth & expansion and the need for professional expert advice & guidance. Another important differentiator that enables GMDC to stand out is our in-depth market knowledge and comprehensive understanding of the Middle Eastern market trends and culture coupled into our western business values and ethics.
GMDC SERVICES:
✔ Initial Market assessment of your products.
✔ Market access.
✔ Regulatory strategy pathway advice assistance and guidance.
✔ Contractual pathway guidance.
✔ Business planning and due diligence.
✔ Distributor assessment (relative to your medical devices speciality).
✔ Distributor selection & allocation assistance.
✔ Distributor commercial training.
✔ Country by country data analytics .
✔ KOL and end-user data base country by country.
✔ Procedure data (relevant to your clinical applications).
✔ Commercialization, Reimbursement and marketing strategy.
✔ Post-Market surveillance.
✔ Centres of excellence initial set-up phase.
✔ Data on Regional congresses, symposiums, and conferences.
✔ Iranian medical devices market access tailored plans. Non USA companies straight forward. USA based companies special approval via OFAC license submission and US government approval.
✔ Product distribution and re-distribution.
We offer an attractive incentive based payable reward as a result of any medical devices referral lead that is then converted into a real business case partnership and opportunity for GMDC. Please get in touch to know more about this opportunity.
www.gulfmedicaldevicesconsultancy.com
Company’s Keywords:
medical, consultancy, gulf, medical devices, distributors, commercialisation, commercialization, market access, regulatory, contractual, market assessment, healthcare, emea, mena
<6
<
<
<2018